Amyloid-β precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress

Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG . (2003). Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161: 41–54.

Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW et al. (2000). PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14: 704–718.

Bargonetti J, Manfredi JJ . (2002). Multiple roles of the tumor suppressor p53. Curr Opin Oncol 14: 86–91.

Bayer TA, Cappai R, Masters CL, Beyreuther K, Multhaup G . (1999). It all sticks together – the APP-related family of proteins and Alzheimer's disease. Mol Psychiatry 4: 524–528.

Bayer TA, Paliga K, Weggen S, Wiestler OD, Beyreuther K, Multhaup G . (1997). Amyloid precursor-like protein 1 accumulates in neuritic plaques in Alzheimer's disease. Acta Neuropathol (Berl) 94: 519–524.

Brummelkamp TR, Bernards R, Agami R . (2002). Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243–247.

Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS et al. (1999). Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. J Neurosci 19: 7860–7869.

Culmsee C, Mattson MP . (2005). p53 in neuronal apoptosis. Biochem Biophys Res Commun 331: 761–777.

de la Monte SM, Sohn YK, Wands JR . (1997). Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152: 73–83.

Eggert S, Paliga K, Soba P, Evin G, Masters CL, Weidemann A et al. (2004). The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation. J Biol Chem 279: 18146–18156.

el-Deiry WS . (1998). Regulation of p53 downstream genes. Semin Cancer Biol 8: 345–357.

el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B . (1992). Definition of a consensus binding site for p53. Nat Genet 1: 45–49.

Galvan V, Chen S, Lu D, Logvinova A, Goldsmith P, Koo EH et al. (2002). Caspase cleavage of members of the amyloid precursor family of proteins. J Neurochem 82: 283–294.

Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E et al. (1997). Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res 25: 151–157.

Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, Rulicke T et al. (2000). Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci 20: 7951–7963.

Kim TW, Wu K, Xu JL, McAuliffe G, Tanzi RE, Wasco W et al. (1995). Selective localization of amyloid precursor-like protein 1 in the cerebral cortex postsynaptic density. Brain Res Mol Brain Res 32: 36–44.

Ko SY, Lin SC, Chang KW, Wong YK, Liu CJ, Chi CW et al. (2004). Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int J Cancer 111: 727–732.

LaFerla FM, Hall CK, Ngo L, Jay G . (1996). Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. J Clin Invest 98: 1626–1632.

Li Q, Sudhof TC . (2004). Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. J Biol Chem 279: 10542–10550.

Lorent K, Overbergh L, Moechars D, De Strooper B, Van Leuven F, Van den Berghe H . (1995). Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, alpha-2-macroglobulin and the 40 000 molecular weight receptor-associated protein. Neuroscience 65: 1009–1025.

Mattson MP . (2004). Pathways towards and away from Alzheimer's disease. Nature 430: 631–639.

McNamara MJ, Ruff CT, Wasco W, Tanzi RE, Thinakaran G, Hyman BT . (1998). Immunohistochemical and in situ analysis of amyloid precursor-like protein-1 and amyloid precursor-like protein-2 expression in Alzheimer disease and aged control brains. Brain Res 804: 45–51.

Meng JY, Kataoka H, Itoh H, Koono M . (2001). Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. Int J Cancer 92: 31–39.

Milyavsky M, Tabach Y, Shats I, Erez N, Cohen Y, Tang X et al. (2005). Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation. Cancer Res 65: 4530–4543.

Moll UM, Ostermeyer AG, Haladay R, Winkfield B, Frazier M, Zambetti G . (1996). Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol Cell Biol 16: 1126–1137.

Morrison RS, Kinoshita Y . (2000). The role of p53 in neuronal cell death. Cell Death Differ 7: 868–879.

Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, Kondratov R et al. (1996). Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci USA 93: 10309–10314.

Pietrzik CU, Hoffmann J, Stober K, Chen CY, Bauer C, Otero DA et al. (1998). From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells. Proc Natl Acad Sci USA 95: 1770–1775.

Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . (1997). A model for p53-induced apoptosis. Nature 389: 300–305.

Ryan KM, Phillips AC, Vousden KH . (2001). Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13: 332–337.

Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129–1136.

Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M et al. (2006). Regulation of AIF expression by p53. Cell Death Differ 13: 2140–2149.

Takahashi M, Dore S, Ferris CD, Tomita T, Sawa A, Wolosker H et al. (2000). Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 28: 461–473.

Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V . (2004). Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene 23: 5759–5769.

Vousden KH, Lu X . (2002). Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594–604.

Ward MW, Kogel D, Prehn JH . (2004). Neuronal apoptosis: BH3-only proteins the real killers? J Bioenerg Biomembr 36: 295–298.

Wasco W, Bupp K, Magendantz M, Gusella JF, Tanzi RE, Solomon F . (1992). Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. Proc Natl Acad Sci USA 89: 10758–10762.